SANGAMO THERAPEUTICS INC's ticker is SGMO and the CUSIP is 800677106. A total of 179 filers reported holding SANGAMO THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 0.39 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $160 | -46.5% | 265,113 | +15.4% | 0.00% | – |
| Q2 2023 | $299 | -24.7% | 229,823 | +2.1% | 0.00% | – |
| Q1 2023 | $397 | -21.1% | 225,190 | +40.6% | 0.00% | – |
| Q4 2022 | $503 | -99.9% | 160,151 | +3.2% | 0.00% | – |
| Q3 2022 | $761,000 | +25.6% | 155,136 | +6.0% | 0.00% | – |
| Q2 2022 | $606,000 | -25.8% | 146,310 | +4.1% | 0.00% | – |
| Q1 2022 | $817,000 | -21.1% | 140,610 | +1.8% | 0.00% | – |
| Q4 2021 | $1,036,000 | +29.7% | 138,166 | +55.7% | 0.00% | – |
| Q3 2021 | $799,000 | -18.5% | 88,713 | +8.4% | 0.00% | – |
| Q2 2021 | $980,000 | -12.5% | 81,832 | -8.4% | 0.00% | – |
| Q1 2021 | $1,120,000 | -49.0% | 89,381 | -36.5% | 0.00% | – |
| Q4 2020 | $2,197,000 | +47.7% | 140,770 | -10.6% | 0.00% | – |
| Q3 2020 | $1,487,000 | +5.5% | 157,403 | 0.0% | 0.00% | – |
| Q2 2020 | $1,410,000 | +31.0% | 157,403 | -6.8% | 0.00% | – |
| Q1 2020 | $1,076,000 | +5.4% | 168,969 | +38.6% | 0.00% | – |
| Q4 2019 | $1,021,000 | -6.8% | 121,948 | +0.8% | 0.00% | – |
| Q3 2019 | $1,095,000 | -4.1% | 120,996 | +14.1% | 0.00% | – |
| Q2 2019 | $1,142,000 | +13.4% | 106,068 | +0.5% | 0.00% | – |
| Q1 2019 | $1,007,000 | -16.6% | 105,569 | +0.3% | 0.00% | – |
| Q4 2018 | $1,208,000 | -40.5% | 105,269 | -12.1% | 0.00% | – |
| Q3 2018 | $2,030,000 | +18.6% | 119,793 | -0.7% | 0.00% | – |
| Q2 2018 | $1,712,000 | +43.0% | 120,595 | +91.5% | 0.00% | – |
| Q1 2018 | $1,197,000 | +3.1% | 62,983 | -11.0% | 0.00% | – |
| Q4 2017 | $1,161,000 | +1.4% | 70,800 | -7.2% | 0.00% | – |
| Q3 2017 | $1,145,000 | +46.6% | 76,300 | -14.0% | 0.00% | – |
| Q2 2017 | $781,000 | +17.1% | 88,700 | -30.8% | 0.00% | – |
| Q1 2017 | $667,000 | +52.6% | 128,200 | -10.5% | 0.00% | – |
| Q4 2016 | $437,000 | -34.1% | 143,200 | 0.0% | 0.00% | – |
| Q3 2016 | $663,000 | +16.3% | 143,200 | +45.4% | 0.00% | – |
| Q2 2016 | $570,000 | +16.8% | 98,500 | +22.2% | 0.00% | – |
| Q1 2016 | $488,000 | -15.1% | 80,600 | +27.9% | 0.00% | – |
| Q4 2015 | $575,000 | +47.1% | 63,000 | -9.2% | 0.00% | – |
| Q3 2015 | $391,000 | -43.3% | 69,400 | +11.8% | 0.00% | – |
| Q2 2015 | $689,000 | -12.3% | 62,100 | +24.0% | 0.00% | – |
| Q1 2015 | $786,000 | +9.9% | 50,100 | +6.6% | 0.00% | – |
| Q4 2014 | $715,000 | +41.0% | 47,000 | 0.0% | 0.00% | – |
| Q3 2014 | $507,000 | -11.1% | 47,000 | +26.0% | 0.00% | – |
| Q2 2014 | $570,000 | -15.4% | 37,300 | 0.0% | 0.00% | – |
| Q1 2014 | $674,000 | -25.8% | 37,300 | -43.0% | 0.00% | – |
| Q4 2013 | $908,000 | +117.7% | 65,400 | +64.3% | 0.00% | – |
| Q3 2013 | $417,000 | -33.0% | 39,800 | -50.0% | 0.00% | – |
| Q2 2013 | $622,000 | – | 79,600 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RA Capital Management | 6,000,000 | $66,540,000 | 6.69% |
| FIC CAPITAL INC | 787,529 | $8,734,000 | 3.47% |
| RA Capital Management | 1,220,209 | $13,532,000 | 1.36% |
| PRINCETON CAPITAL MANAGEMENT INC | 114,120 | $1,266,000 | 0.67% |
| Perceptive Advisors | 800,000 | $8,872,000 | 0.53% |
| Cormorant Asset Management, LP | 361,000 | $4,003,000 | 0.53% |
| Highlander Capital Management, LLC | 43,500 | $482,000 | 0.43% |
| APEX CAPITAL, LLC | 439,900 | $4,878,000 | 0.42% |
| WASATCH ADVISORS LP | 3,091,386 | $34,283,000 | 0.37% |
| Baker Brothers Advisors | 3,230,932 | $35,831,000 | 0.31% |